Posted inBiotechnology
Posted inBiotechnology
Satellos’ ‘intriguing’ Duchenne data raise hopes ahead of key readout
Satellos Bioscience has shared evidence that its Duchenne muscular dystrophy drug candidate is active in adults, leading analysts to predict…









